IDYA
IDYA
NASDAQ · Biotechnology

Ideaya Biosciences Inc

Mid-Cap Stocks Biotech Stocks Healthcare Stocks
$28.32
+0.08 (+0.28%)
As of May 9, 1:26 AM ET ·
Analyst Consensus
Strong Buy
25
Analysts
High
Coverage
Buy 22 88%
Hold 3 12%
Sell 0 0%
Price Target
Analyst Price Target +315.5% upside
Low Target $81.99
Average Target $117.67
High Target $158.58
Current Price $28.32
Current
$28.32
Target
$117.67
$81.99 $117.67 avg $158.58
Scenario Analysis
Bear Case
$81.99
189.5%
Low target
Base Case
$117.67
+315.5%
Avg target
Bull Case
$158.58
+460.0%
High target
Risk/Reward
2.4x
Favorable
Price in Context
52-Week High
$39.28
-27.9% from high
52-Week Low
$16.82
+68.4% from low
50-Day SMA
$34.24
-17.3% vs SMA
200-Day SMA
$27.52
+2.9% vs SMA
RSI (14)
49.6
Neutral
Target vs 52W High
$117.67
+199.6% vs high
Peer Consensus — Biotechnology
Stock Consensus Analysts Buy % Target Upside
ABBV
Abbvie Inc
 Buy 39 72% $257.58 +27.8%
AMGN
Amgen Inc
 Hold 43 49% $190.87 -42.5%
GILD
Gilead Sciences Inc
 Strong Buy 39 79% $362.68 +176.2%
VRTX
Vertex Pharmaceuticals Inc
 Strong Buy 39 79% $438.34 +2.0%
REGN
Regeneron Pharmaceuticals
 Strong Buy 38 79% $76.80 -89.3%
ALNY
Alnylam Pharmaceuticals Inc
 Strong Buy 36 75% $102.31 -65.3%
RVMD
Revolution Medicines Inc
 Strong Buy 27 96% $114.11 -19.5%
INSM
Insmed Inc
 Strong Buy 26 96% $143.40 +41.5%